SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-002594
Filing Date
2019-01-04
Accepted
2019-01-04 17:02:09
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d681933ds3.htm S-3 260254
2 EX-4.6 d681933dex46.htm EX-4.6 378988
3 EX-5.1 d681933dex51.htm EX-5.1 32578
4 EX-23.1 d681933dex231.htm EX-23.1 2239
5 GRAPHIC g6819335_1ex.jpg GRAPHIC 6239
6 GRAPHIC g681933g01i11.jpg GRAPHIC 12158
7 GRAPHIC g681933g05h77.jpg GRAPHIC 42863
  Complete submission text file 0001193125-19-002594.txt   759786
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229140 | Film No.: 19510920
SIC: 2834 Pharmaceutical Preparations